An investigation of probiotic lactobacilli on activation of anti-oxidative system, reduction of inflammatory markers, and inhibition of alpha-glucosidase (α-G) and dipeptidyl peptidase 4 (DPP4) indicates potential for therapy of type 2 diabetes.

Harsh Panwar, Brian Green, Irene Grant, V.K. Batish , Sunita Grover

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
JournalSfAM summer conference, Cardiff, Wales
Publication statusPublished - 2013

Cite this